Recent studies have shown that CF is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), and CFTR potentiators have been shown to be useful in reducing disease progression in patients with CF (Elborn, 2016; Middleton et al., 2019). This evidence concerns the gene CFTR and cystic fibrosis.